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http://dx.doi.org/10.1016/j.jfma.201Spinal cord involvement in gliomatosis cerebri (GC) is uncommon. We report two patients with
GC, who initially presented with chronic meningitis and were treated with antituberculous
drugs. Although tumor meningitis was suspected, due to the intractable clinical course,
a correct diagnosis was established after performing a biopsy examination of the metastatic
spinal lesion which was detected by magnetic resonance imaging (MRI). Cerebrospinal fluid
examination, including cytology, should be performed repetitively for patients with chronic
meningitis refractory to antibiotic treatment. Spinal MRI is necessary for the complete neuro-
logical workup, even when the patients do not show spinal symptoms.
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Gliomatosis cerebri (GC) is a rare brain neoplasm involving
widespread infiltration into the central nervous system,have no conflicts of interest
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2.10.024with the underlying cytoarchitecture preserved.1 GC is
a diffuse glial tumor, extensively infiltrating the brain,
involving more than two lobes (frequently bilateral), and
often extending to the infratentorial structures.2 Although
9% of GC cases involve the spinal cord, the spinal cord
lesion is seldom observed during radiography.3 Antemortem
diagnosis is difficult, and most cases are diagnosed at
postmortem. GC may mimic infective lesions owing to the
vagueness of the physical, radiological, and pathological
findings. Leptomeningeal involvement may be mistaken for& Formosan Medical Association. All rights reserved.
Gliomatosis cerebri presenting with chronic meningitis 887tuberculous meningitis, because both have similar presen-
tations and imaging characteristics. By empirical treatment
of GC with antituberculous medication, the condition may
progress to an advanced stage. We report that two patients
had GC with metastatic spinal lesions confirmed by
pathology, which aided correct diagnosis and treatment.
Case reports
Case 1
A normal and healthy 11-year-old boy had a first episode of
unprovoked generalized tonic-clonic seizure with loss of
consciousness, preceded by an intermittent severe explo-
sive headache, for 3 days. Head computed tomography (CT)
revealed hyperdensity in the left Sylvian fissure and hypo-
density in the adjacent brain parenchyma (Fig. 1A). Brain
magnetic resonance imaging (MRI) revealed diffuse lep-
tomeningeal changes, suggesting tuberculous (TB) menin-
gitis, cryptococcal meningitis, or tumor seeding (Fig. 1B).
Cerebrospinal fluid (CSF) examination revealed pleocytosis
[WBC Z 125/mm3; lymphocyte:neutrophil:monocyte
(L:N:M) Z 30:4:6], an elevated protein level (206 mg/dL;
normal range Z 20w45 mg/dL), and a normal glucose
level. The results of India ink staining, cultures of bacteria,
fungus, virus, and TB, and TB polymerase chain reaction
(PCR) in the CSF were negative. Electroencephalography
(EEG) revealed focal epileptiform discharges in the left
frontocentral area and mild-to-moderate diffuse cerebral
dysfunction mainly in the posterior head. Consciousness
was restored 2 days after lumbar puncture, and the patient
was discharged without neurological deficit 6 days after
admission.
The second episode of intermittent headache and
unsteady gait occurred 18 days after the first attack.
Follow-up MRI revealed more intense and diffuse lep-
tomeningeal changes, with left temporal lobe involvement
(Fig. 1C). CSF examination revealed pleocytosis
(WBC Z 87/mm3; L:N Z 60:27) and a high protein level
(909.6 mg/dL), but a normal glucose level (45 mg/dL). No
malignant cells were observed on cytological examination.
TB meningitis was suspected, and the antituberculosis
drugs and mannitol were prescribed. Frequent vomiting and
conscious disturbance, with bradycardia and hypertension,
and progressive hydrocephalus in the brain CT, indicated
ventriculoperitoneal shunt insertion. The repeated CSF
examinations with TB PCR and enzyme-linked immunosor-
bent spot (ELISPOT) assay yielded negative results.
Approximately 70 days after the first attack, he
suffered another seizure with upward gaze, mouth
twitching, drooling, bilateral hand spasm, and aphasia.
EEG revealed focal epileptiform discharges in the left
temporal area and moderate diffuse cerebral dysfunction
predominantly over the left hemisphere. Antiepileptic
drugs such as phenobarbital, carbamazepine, and valproic
acid were administered. Neurological examination
revealed focal weakness in the right lower extremity and
asymmetric deep tendon reflexes. Brain MRI revealed
diffuse leptomeningeal changes, with left temporal lobe
involvement. CSF examination revealed pleocytosis
(WBC Z 41/mm3; L:N Z 35:6) and an extremely highprotein level (4100 mg/dL). Cytological examination
showed one malignant cell. Spine MRI revealed a nodular
lesion (1.5 cm in diameter) in the subarachnoid space at
T5-6 (Fig. 1D). The intradural extramedullary tumor was
partially excised, because it was tightly attached to and
infiltrated the dorsal surface of the spinal cord. The
pathology revealed anaplastic astrocytoma (Fig. 1E and F).
Chemotherapy with temozolomide (4 cycles: 75 mg/m2/
day for 6 weeks and 200 mg/m2/day for 5 days) and
radiotherapy (54 Gy, brain; 40 Gy, spine) were adminis-
tered in another medical center. Peritoneal carcinomatosis
and massive ascites developed, and he died of multiple
organ failure at 12 months after disease onset.Case 2
A 13-year-old Taiwanese boy, living in mainland China, was
generally healthy until the onset of acute blurred vision,
gait disturbance, and dizziness. Progressive right limb
numbness, abnormal proprioception, and projectile vomit-
ing developed gradually for 1 month. In the hospital of
China, brain CT revealed no abnormality, but brain MRI
showed signal changes in the right periventricular, bilateral
thalamus, and brain stem, indicating inflammation. Aseptic
meningitis or TB meningitis was suspected, according to an
elevated opening pressure (>40 cm H2O), an elevated CSF
protein level (400 mg/dL), and a weakly positive response
in the tuberculin-purified protein derivative test. The
antituberculous drugs were empirically administered, even
though no definite pathogen was isolated. Gait disturbance
and vomiting improved after reducing the intracranial
pressure (ICP). Unfortunately, a generalized toniceclonic
seizure occurred 1 month after the onset of blurred vision
and the antiepileptic drug therapy was administered. He
was then transferred to our hospital.
On admission, neurological examination revealed a slug-
gish light reflex, right peripheral facial palsy, and
decreased tendon reflexes in bilateral knees. Brain MRI
revealed multiple focal lesions at the pons, both medial
thalami and the left parieto-occipital, central and right
genu of the corpus callosum (Fig. 2A). Cryptococcus
meningitis or postinfection changes were suspected, and
the lesions were less likely cancerous. Spine MRI showed
vague signal changes at T11-12. EEG showed mild and
diffuse cerebral dysfunction. CSF examination revealed
pleocytosis (WBC Z 8/mm3; L:N Z 7:1), a normal glucose
level (46 mg/dL), an elevated protein level (385.6 mg/dL),
and an elevated opening pressure (>60 cm H2O). The
results of India ink staining, cultures of bacteria, fungus,
virus, and TB, and TB PCR in the CSF were negative.
Even after anti-increased intracranial pressure (IICP)
therapy, blurred vision was exacerbated gradually. Brain
biopsy in the right frontal lobe revealed glial tissues with
low cellularity, suggesting reactive glial proliferation or
malignancy. Because the reactive glial proliferation was
more favored, we started methylprednisolone pulse
therapy (1 g/day) for 5 days. The numbness in his right
lower limb worsened, and unsteady gait and weakness
developed after treatment. Neurological examination
revealed reduction in the muscle power, temperature
sensation, and light touch below L1. The repeated spinal
Figure 1 Case 1: (A) head computed tomography (CT) revealed hyperdensity in the left Sylvian fissure and hypodensity in the
adjacent brain parenchyma; (B) brain magnetic resonance imaging (MRI) with contrast reveals diffuse leptomeningeal changes
within the posterior fossa, basal cisterns, and both Sylvian fissures; (C) follow-up MRI revealed more intense and diffuse lep-
tomeningeal changes, with left temporal lobe involvement; (D) spine MRI with contrast reveals an enhanced nodular lesion about
1.5 cm in diameter in the subarachnoid space at the level of T5e6, compressing the adjacent spinal cord (arrow). (E) Cellular
tumor, containing mainly plump spindle cells with vague fascicular pattern, is observed. Cellular pleomorphism and brisk mitotic
figures and epithelioid cell foci, with abundant eosinophilic cytoplasm in a fibrillary background, are noted (hematoxylin and eosin
stain, 400). (F) Immunohistochemically, the tumor cells are diffusely positive for glial fibrillary acidic protein (GFAP, 400).
888 Y.-H. Lin et al.MRI revealed high signal intensity near T11e12 with mild
spinal swelling (Fig. 2B), suggesting an intramedullary
tumor, with leptomeningeal seeding. The pathology by open
biopsy revealed glioblastoma (Fig. 2C and D). We started
radiotherapy (30 Gy, brain; 40 Gy, spine) and chemotherapywith temozolomide (75 mg/m2/day for 3 weeks, and 3
cycles of 200 mg/m2/day for 5 days over the next 3 months).
A brainespine MRI at 5 months after diagnosis showed no
abnormal signal changes at the pons, both thalami, and the
corpus callosum, except for some postoperative changes in
Figure 2 Case 2: (A) coronal brain magnetic resonance imaging (MRI) reveals multiple focal lesions, with high signal intensity on T2
fluid-attenuated inversion recovery (FLAIR), at the lower and upper pons, both medial thalami, and the left central parieto-occipital
parenchyma; (B) sagittal spine MRI shows abnormal high signal intensity near the level of T11e12, with mild cord swelling in
T2-weighted image (arrow). (C) Anaplastic cellular tumor is composed of poorly differentiated, often pleomorphic tumor cells, with
marked nuclear atypia and scant cytoplasm. Enhanced mitotic activity indicates necrosis with peripheral palisading (hematoxylin
and eosin stain, 400). (D) Immunohistochemically, the tumor cells are diffusely positive for GFAP (100).
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disease onset, the patient has normal consciousness and is
neurologically stable, under regular chemotherapy at our
hospital, with the sequelae of near blindness, lower limb
paralysis, and loss of sensation below T12.Discussion
Patients with GC may have subtle and nonspecific clinical
findings,4 and their clinical symptoms are variable. The
most common initial symptoms are mental and behavioral
changes, headaches and seizures.5 The duration of symp-
toms before diagnosis is different, indicating the differ-
ences in the extent of disease, aggressiveness of tumor
invasion, and level of suspicion for a neoplasm requiring
radiological or surgical intervention.4 GC diagnosis by neu-
roimaging techniques and biopsy is also difficult. GC has
been diagnosed during life in only 12/118 reported cases
(10%) since 1938 in a literature survey.6 There were much
fewer case reports of GC with spinal cord involvement
documented by pathology.3
In our patients, the initial diagnosis of TB meningitis was
based on clinical symptoms, neurologic manifestation, andCSF findings, although there was no direct evidence from
cultures and PCR. Fungal infections or malignancy should
be suspected in the patients who are refractory to the
antibiotic treatment.7 It is difficult to identify the cause of
chronic meningitis, especially when the results of micro-
biological, cytological, and molecular tests are all nega-
tive.7 Nevertheless, intractable IICP, persistent elevation of
CSF protein levels and pleocytosis suggest a neoplastic
process. The repeated CSF examination has identified
malignant cells in approximately 80% of leptomeningeal
carcinomatosis and 66% of secondary meningeal gliomatosis
cases.8 We performed an examination of CSF specimens,
because it was of critical importance for early diagnosis of
TB meningitis after a space occupying mass lesion had been
excluded by brain CT and MRI. However, the CSF findings of
our two patients, from more than three lumbar punctures,
were nearly negative, suggesting the poor performance of
this method for diagnosing GC.
Spinal cord involvement was noted in our patients,
although they were asymptomatic at the initial presenta-
tion. Based on our experience of the first patient, we listed
CNS malignancy in the differential diagnosis for the second
patient. However, CSF cytological examination generally
showed negative results for GC9 which made its diagnosis
890 Y.-H. Lin et al.complicated. Biopsy is essential for antemortem diagnosis.
However, the histological examination is frequently unre-
warding, and only reactive gliosis can be identified in
a limited biopsy,10 similar to the brain biopsy in our second
case. The pathology of the localized metastatic spinal
tumor, confirmed the diagnosis, and allowed correct
treatment in both patients. There were only a few case
reports of GC with spinal cord involvement in which the
symptoms of a brain lesion could not be distinctly differ-
entiated from those of a spinal cord lesion.3 Spine MRI is
recommended in the complete workup for GC.
GC has an extremely variable prognosis, and its optimal
treatment is not well established. Owing to its toxicity
profile and lack of cumulative toxicity, temozolomide is
used for treating slow-responding tumors and is the first-
choice treatment for patients with GC.11 Our first patient
had diffuse leptomeningeal gliomatosis, with progressive
hydrocephalus, which was relieved by a ventriculoper-
itoneal shunt. However, abdominal metastasis via the
ventriculoperitoneal shunt led to treatment failure. GC
complicated with hydrocephalus is rare.5 An internal CSF
diversionary shunt should be avoided if brain tumor
patients develop hydrocephalus. Percutaneous long-
tunneled ventricular drainage in patients with secondary
obstructive hydrocephalus, due to intracranial germ cell
tumors or medulloblastoma, can prevent the potential risk
of intraperitoneal metastasis and minimize the risk of
infection.12 The external drain is removed after definite
treatment of the tumor. However, treatment of communi-
cating hydrocephalus would require a permanent internal
CSF shunt, which is relatively contraindicated in lep-
tomeningeal carcinomatosis or gliomatosis. Therefore,
ventriculoperitoneal shunt implantation should not be
performed in chronic meningitis patients with hydroceph-
alus, unless a neoplastic condition is excluded.
Herein, we report that two patients who presented with
chronic meningitis, turned out to have GC. GC is the
possible neoplastic cause in patients with chronic menin-
gitis refractory to antituberculous treatment. Spinal MRI isnecessary for the complete workup of GC, to facilitate
early and correct diagnosis and treatment.References
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